SFZ DS Tablet & ATZ 50 Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
SFZ DS Tablet & Azoran Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
SFZ DS Tablet & Zesoris-AZ 50mg Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
SFZ DS Tablet & Autorin 50mg Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
SFZ DS Tablet & Vaprin Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
SFZ DS Tablet & Azoalfa Tablet 50
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
SFZ DS Tablet & Azanol Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
SFZ DS Tablet & Azin Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
SFZ DS Tablet & Imuzat 50mg Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
SFZ DS Tablet & Azafly 50mg Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details